SCHEMBL22282959

SCHEMBL22282959

CC(C)CCC(c1ccc(NCCC(=O)O)cc1)n1ccc2cc(-c3ccc(C(F)(F)F)cc3)ccc21

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 19/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19922822 0.90 GCGR (0.86) GCGR
SCHEMBL19922907 0.85 GCGR (0.65) GCGR
SCHEMBL19922780 0.82 GCGR (1.00) GCGR
SCHEMBL19922820 0.82 GCGR (0.81) GCGR
SCHEMBL19922776 0.80 GCGR (0.79) GCGR
SCHEMBL19922811 0.80 GCGR (0.78) GCGR
SCHEMBL19922855 0.80 GCGR (0.69) GCGR
SCHEMBL19922783 0.79 GCGR (0.77) GCGR
SCHEMBL19922764 0.79 GCGR (0.77) GCGR
SCHEMBL19922844 0.79 GCGR (0.76) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510022-B1 INDOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2020-08-05 EP disclosed